Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06660589Not Yet Recruiting

Feasibility Study of Telerehabilitation for People with Chronic Obstructive Pulmonary Disease in Nuuk

Role: lead

NCT06264427Not ApplicableRecruiting

Phenotypic and Genotypic Characterization of Patients With Dysmetabolism in Greenland

Role: lead

NCT05747118Completed

A Feasibility Study of a 12 Week Training Intervention With Patients With Type 2 Diabetes and MODY in Greenland

Role: lead

NCT05375656Not ApplicableCompleted

The Effect on Metabolism, Food Intake and Preferences of a Knockout Gene Variant Involved in Carbohydrate Metabolism

Role: collaborator

All 4 trials loaded